Table 3.
Numbers of DC-ATA products injected by clinical trial. Numbers reported are the average numbers of cells injected during each of the first three injections.
| Trial | # patients | Median # cells injected x 106 |
Mean # cells injected x 106 ± standard deviation |
Lowest # cells injected x 106 |
Highest # cells injected x 106 |
|---|---|---|---|---|---|
| Renal Cell | 9 | 12.8 | 14.9 ± 7.4 | 6.0 | 28.2 |
| Melanoma | 54 | 15.0 | 15.4 ± 6.4 | 4.8 | 33.1 |
| Melanoma | 18 | 13.0 | 12.5 ± 3.7 | 5.7 | 19.1 |
| Hepatoma | 8 | 6.6 | 8.6 ± 4.5 | 4.4 | 16.0 |
| Ovary | 28 | 7.0 | 10.7 ± 9.0 | 0.52 | 29.0 |
| GBM | 57 | 8.5 | 10.3 ± 7.8 | 0.27 | 27.0 |